Future Vaccines Depend on Test Subjects in Short Supply: Monkeys
Dr. Reeves spoke to the NYT about the future of vaccine research studies’ dependency on test subjects. Read Article
Dr. Reeves spoke to the NYT about the future of vaccine research studies’ dependency on test subjects. Read Article
Vaccine makers are designing follow-up shots, based on new mutations, to keep the disease at bay. Read Article
Dr. Nkolola spoke to the Zambia Daily Mail about his role in developing a COVID-19 vaccine. Read Article
Facing new variants of SARS-CoV-2, some vaccines may offer more robust protection or be more easily redesigned to target them. Read Article
Dr. Dan Barouch, the director of Beth Israel’s Center for Virology and Vaccine Research who led design efforts for the vaccine alongside Johnson & Johnson, answers questions around the new vaccine. Read Article
Johnson & Johnson Chief Scientific Officer Dr. Paul Stoffels, Harvard’s Dr. Dan Barouch and others discuss where we are in the fight against COVID-19 and learn what’s next for vaccine development. Plus, other news with Dr. Uché Blackstock.
The company says trials for its drug show that efficacy takes hold in 7 to 10 days. Read Article
Dr. Kathryn Stephenson of Harvard University responded to questions about how quickly immunity begins after vaccination, the vaccine development timeline, and whether face masks are necessary after vaccination, the sheriff’s office said in a statement. Read Article
“We thought it was important,” Barouch recalled. “Never in our wildest imagination did we think it would grow to 90 million cases [worldwide] a year later.” Read Article

3 Blackfan Circle
Boston, MA 02115 – USA
T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu
T 617.735.4610
E CVVRtrials@bidmc.harvard.edu
[DISPLAY_ULTIMATE_SOCIAL_ICONS]
